In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...

Researchers at University of Tsukuba have developed the Japanese version of the community-based rehabilitation indicators ...

The Rutgers Krieger Klein Alzheimer's Research Center has received a $1.5 million philanthropic gift from the Norman and Mary ...

Google LLC is seeking to expedite scientific and medical studies by partnering with Japanese universities and offering the ...

Detailed price information for Acumen Pharmaceuticals Inc (ABOS-Q) from The Globe and Mail including charting and trades.

In a new study published in Neurochemistry International, scientists from Kindai University in Japan discovered that a common ...

Maintaining long-term health has become a major challenge, driving research into ways to extend “healthspan” rather than ...

B. Joy Snider's clinic focuses on early detection of memory issues, using biomarkers for precise Alzheimer's diagnosis and ...

As Japan continues to see a rise in dementia patients, the country is actively adopting advanced IT technologies to address ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Houston Methodist neuroscientists have developed a first-of-its-kind method to rapidly produce synchronized, human brain wave ...